Pure Global AI
Manufacturer profile

ROCHE MOLECULAR SYSTEMS

IndonesiaUnited States8 products registered
VerifiedKemenkes (Ministry of Health) · official registry
8
Total Products
8
Product Names
2
Product Classes
3
Risk Classes
Regulatory footprint
Search ROCHE MOLECULAR SYSTEMS across other regulatory registries
Risk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B225.0% of total
Kelas Resiko : C562.5% of total
Kelas Resiko : D112.5% of total
Product class portfolio
Products organized by product class
Kelas : 2
COBAS SARS-CoV-2 Nucleic acid test for use on the cobas Liat System, COBAS PIK3CA Mutation Test (PIK3CA), COBAS MTB Positive Control Kit for use on the cobas 6800/8800 Systems, COBAS MTB Nucleic acid test for use on the cobas 6800/8800 Systems, cobas SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas Liat Systems ... and 2 more products in this class
7 Products
Kelas : 3
COBAS HBV
1 Products
Recent registrations (8 most recent)
Most recently registered products with Ministry of Health
About this profile

ROCHE MOLECULAR SYSTEMS from United States is a medical device manufacturer with 8 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 8 unique product types across 2 product classes.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.